John Martin
Molecular and Cell Biology
 Regeneus
Australia
Biography
John has been an Executive Director since 2009 and was appointed CEO in November 2014. John has over 20 years of experience as a business executive, director and corporate lawyer including roles as CEO and Director of ASX listed and private emerging technology companies including BTF and Proteome Systems. John was a corporate and executive partner of Allens specialising in M&A, fundraising and life sciences.
Research Interest
Molecular and Cell Biology
